Li Jing, Gao Jie, Xu Ya-ping, Zhou Tong-liang, Jin Yao-ying, Lou Jin-ning
Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, China.
Zhonghua Yi Xue Za Zhi. 2007 Mar 27;87(12):833-7.
To investigate the expression of the 2 severe acute respiratory syndrome coronavirus (SARS-CoV) receptors, angiotensin-converting enzyme 2 (ACE2) and CD209L in different human organ/tissue derived microvascular endothelial cells.
Endothelial cells from the microvessels in human brain, lung, hepatic sennoside, fat adipose tissue, adrenal gland, esophagus, lymph nodes, and bone were culture. RT-PCR, Western blotting and immunocytochemistry were used to detect the expression of ACE2 and CD209L receptors.
Both SARS-CoV receptors of ACE2 and CD209L were expressed in the 8 organ/tissue-derived endothelial cells. The expression of ACE2 receptor was the highest in the human lung microvascular endothelial cells, and lowest in the lymphatic endothelial cells. The expression of CD209L was relatively higher in the human lymphatic endothelial cells.
The organ derived microvascular endothelial cells are the important target of SARS-CoV. The pathological injury of lung and lymph system induced by SARS-CoV may be mediated respectively by different receptors of SARS-CoV.
研究2种严重急性呼吸综合征冠状病毒(SARS-CoV)受体,即血管紧张素转换酶2(ACE2)和CD209L在不同人源器官/组织微血管内皮细胞中的表达情况。
培养来自人脑、肺、肝、脂肪组织、肾上腺、食管、淋巴结和骨微血管的内皮细胞。采用逆转录-聚合酶链反应(RT-PCR)、蛋白质免疫印迹法(Western blotting)和免疫细胞化学法检测ACE2和CD209L受体的表达。
ACE2和CD209L这两种SARS-CoV受体均在8种器官/组织来源的内皮细胞中表达。ACE2受体在人肺微血管内皮细胞中表达最高,在淋巴管内皮细胞中表达最低。CD209L在人淋巴管内皮细胞中的表达相对较高。
器官来源的微血管内皮细胞是SARS-CoV的重要靶标。SARS-CoV引起的肺和淋巴系统病理损伤可能分别由SARS-CoV的不同受体介导。